Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 17 articles: HTML format Text format

Single Articles

February 2019
1. XING Y, Chand G, Liu C, Cook GJR, et al
   Early phase I study of a (99m)Tc labeled anti-PD-L1 single domain antibody in SPECT/CT assessment of programmed death ligand-1 expression in non-small cell lung cancer.
   J Nucl Med. 2019 Feb 22. pii: jnumed.118.224170. doi: 10.2967/jnumed.118.224170.
   PubMed     Text format     Abstract available
   
   
   November 2018
2. ZHUANG M, Vallez Garcia D, Kramer GM, Frings V, et al
   Variability and repeatability of quantitative uptake metrics in [(18)F]FDG PET/CT imaging of non-small cell lung cancer: impact of segmentation method, uptake interval, and reconstruction protocol.
   J Nucl Med. 2018 Nov 2. pii: jnumed.118.216028. doi: 10.2967/jnumed.118.216028.
   PubMed     Text format     Abstract available
   
   
   July 2018
3. TURGEON GA, Iravani A, Akhurst T, Beaulieu A, et al
   What FDG-PET response-assessment method best predicts survival after curative-intent chemoradiation in non-small cell lung cancer (NSCLC): EORTC, PERCIST, Peter Mac or Deauville criteria?
   J Nucl Med. 2018 Jul 20. pii: jnumed.118.214148. doi: 10.2967/jnumed.118.214148.
   PubMed     Text format     Abstract available
   
   
   
4. DE BRUYCKER S, Vangestel C, Van den Wyngaert T, Pauwels P, et al
   (18)F-HX4 Hypoxia PET Holds Promise as a Prognostic and Predictive Imaging Biomarker in a Lung Cancer Xenograft Model Treated with Metformin and Radiotherapy.
   J Nucl Med. 2018 Jul 6. pii: jnumed.118.212225. doi: 10.2967/jnumed.118.212225.
   PubMed     Text format     Abstract available
   
   
   May 2018
5. HAN Z, Xiao Y, Wang K, Yan J, et al
   Development of a Novel SPECT Tracer to Image c-Met Expression in Non-Small Cell Lung Cancer in a Human Tumor Xenograft.
   J Nucl Med. 2018 May 18. pii: jnumed.117.206730. doi: 10.2967/jnumed.117.206730.
   PubMed     Text format     Abstract available
   
   
   April 2018
6. MCHUGH C, Thipparthi MR, Lawhorn-Crews JM, Polin L, et al
   Utilizing radiolabeled 3'-deoxy-3'-[(18)F]fluorothymidine with positron emission tomography to monitor the effect of dexamethasone on non-small cell lung cancer.
   J Nucl Med. 2018 Apr 19. pii: jnumed.117.207258. doi: 10.2967/jnumed.117.207258.
   PubMed     Text format     Abstract available
   
   
   November 2017
7. OLIN A, Ladefoged CN, Langer NH, Keller SH, et al
   Reproducibility of MR-based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer.
   J Nucl Med. 2017 Nov 9. pii: jnumed.117.198853. doi: 10.2967/jnumed.117.198853.
   PubMed     Text format     Abstract available
   
   
   June 2017
8. KRAMER GM, Hoekstra OS, Boellaard R
   Reply: Repeatability of Quantitative Whole Body 18F-FDG PET/CT Uptake Measures in NSCLC Patients: Dynamic versus Test-Retest Design.
   J Nucl Med. 2017 Jun 15. pii: jnumed.117.195461. doi: 10.2967/jnumed.117.195461.
   PubMed     Text format    
   
   
   
9. KRAMER GM, Frings V, Heijtel D, Smit EF, et al
   Parametric Method Performance for Dynamic 3'-Deoxy-3'-18F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Carcinoma Patients Before and During Therapy.
   J Nucl Med. 2017;58:920-925.
   PubMed     Text format     Abstract available
   
   
   May 2017
10. FLEDELIUS J, Winther-Larsen A, Khalil AA, Bylov CM, et al
    18F-FDG-PET/CT for very early response evaluation predicts CT response in Erlotinib treated NSCLC patients - A comparison of assessment methods.
    J Nucl Med. 2017 May 10. pii: jnumed.117.193003. doi: 10.2967/jnumed.117.193003.
    PubMed     Text format     Abstract available
    
    
    
11. STEIGER S, Arvanitakis M, Sick B, Weder W, et al
    Analysis of prognostic values of various PET metrics in preoperative FDG PET for early stage bronchial carcinoma for progression free and overall survival: significantly increased glycolysis is a predictive factor.
    J Nucl Med. 2017 May 10. pii: jnumed.117.189894. doi: 10.2967/jnumed.117.189894.
    PubMed     Text format     Abstract available
    
    
    April 2017
12. MORBELLI S, Alama A, Ferrarazzo G, Coco S, et al
    Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC): an 18F-FDG PET/CT study.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.193201. doi: 10.2967/jnumed.117.193201.
    PubMed     Text format     Abstract available
    
    
    March 2017
13. WARNDERS FJ, Terwisscha van Scheltinga AG, Knuehl C, van Roy M, et al
    HER3 specific biodistribution and tumor uptake of 89Zr-MSB0010853 visualized by real-time and non-invasive PET imaging.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.181586. doi: 10.2967/jnumed.116.181586.
    PubMed     Text format     Abstract available
    
    
    
14. USMANIJ EA, Natroshvili T, Timmer-Bonte JN, Oyen WJ, et al
    The predictive value of early in-treatment FDG-PET/CT response to chemotherapy in combination with bevacizumab in advanced non-squamous non-small cell lung cancer.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.185314. doi: 10.2967/jnumed.116.185314.
    PubMed     Text format     Abstract available
    
    
    January 2017
15. HEKMAN MC, Rijpkema M, Bos D, Oosterwijk E, et al
    Detection of micrometastases using SPECT/fluorescence dual-modality imaging in a CEA-expressing tumor model.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.185470. doi: 10.2967/jnumed.116.185470.
    PubMed     Text format     Abstract available
    
    
    December 2016
16. NOTNI J, Reich D, Maltsev OV, Kapp TG, et al
    In-vivo PET imaging of the "cancer integrin" alphavbeta6 using gallium-68 labelled cyclic RGD nonapeptides.
    J Nucl Med. 2016 Dec 15. pii: jnumed.116.182824.
    PubMed     Text format     Abstract available
    
    
    May 2016
17. CYSOUW MC, Kramer GM, Hoekstra OS, Frings V, et al
    Accuracy and precision of partial volume correction in oncological PET/CT studies.
    J Nucl Med. 2016 May 26. pii: jnumed.116.173831.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: